Founded in 2004 and based in King of Prussia, Pennsylvania, Prism Pharmaceuticals is committed to becoming a leading specialty pharmaceutical company in the acute care cardiovascular market. Their product lineup includes NEXTERONE, an injectable anti-arrhythmic agent, and PM103, an intravenous formulation of clopidogrel bisulfate.